Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Elite Health Systems (EHSI) EBITDA (2016 - 2025)

Elite Health Systems' EBITDA history spans 16 years, with the latest figure at -$1.8 million for Q4 2025.

  • Quarterly results put EBITDA at -$1.8 million for Q4 2025, down 264.98% from a year ago — trailing twelve months through Dec 2025 was -$3.8 million (down 114.05% YoY), and the annual figure for FY2025 was -$3.8 million, down 114.11%.
  • EBITDA for Q4 2025 was -$1.8 million at Elite Health Systems, down from -$1.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $677000.0 in Q1 2021 to a low of -$1.8 million in Q4 2025.
  • The 5-year median for EBITDA is -$326000.0 (2022), against an average of -$393450.0.
  • Peak annual rise in EBITDA hit 84.97% in 2021, while the deepest fall reached 280.43% in 2021.
  • Year by year, EBITDA stood at -$248000.0 in 2021, then crashed by 104.84% to -$508000.0 in 2022, then skyrocketed by 52.17% to -$243000.0 in 2023, then crashed by 103.29% to -$494000.0 in 2024, then crashed by 264.98% to -$1.8 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at -$1.8 million, -$1.2 million, and -$445000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.